Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes.

about

Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes.

Item

http://www.wikidata.org/entity/Q50225588

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Alpha-2-HS-glycoprotein plasma ...... ith myelodysplastic syndromes.

@en

Alpha-2-HS-glycoprotein plasma ...... ith myelodysplastic syndromes.

@nl

type

Item

label

Alpha-2-HS-glycoprotein plasma ...... ith myelodysplastic syndromes.

@en

Alpha-2-HS-glycoprotein plasma ...... ith myelodysplastic syndromes.

@nl

prefLabel

Alpha-2-HS-glycoprotein plasma ...... ith myelodysplastic syndromes.

@en

Alpha-2-HS-glycoprotein plasma ...... ith myelodysplastic syndromes.

@nl

P1476

Alpha-2-HS-glycoprotein plasma ...... with myelodysplastic syndromes

@en

P2093

Bohumir Prochazka

http://www.w3.org/2001/XMLSchema#string

Jan E Dyr

http://www.w3.org/2001/XMLSchema#string

Jaroslav Cermak

http://www.w3.org/2001/XMLSchema#string

Klara Pecankova

http://www.w3.org/2001/XMLSchema#string

Zdenka Gasova

http://www.w3.org/2001/XMLSchema#string

P2860

Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes

alpha2-Heremans Schmid glycoprotein, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunction

Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma.

Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.

Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2.

Fetuin-A protects against atherosclerotic calcification in CKD.

P304

637-639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/CBM-170638

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pavel Májek

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28869442

http://www.w3.org/2001/XMLSchema#string